190 related articles for article (PubMed ID: 34242730)
1. The Role of the GABAergic System in Diseases of the Central Nervous System.
Zhang W; Xiong BR; Zhang LQ; Huang X; Yuan X; Tian YK; Tian XB
Neuroscience; 2021 Aug; 470():88-99. PubMed ID: 34242730
[TBL] [Abstract][Full Text] [Related]
2. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
Bi D; Wen L; Wu Z; Shen Y
Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726
[TBL] [Abstract][Full Text] [Related]
3. GABAergic System Dysfunction in Autism Spectrum Disorders.
Zhao H; Mao X; Zhu C; Zou X; Peng F; Yang W; Li B; Li G; Ge T; Cui R
Front Cell Dev Biol; 2021; 9():781327. PubMed ID: 35198562
[TBL] [Abstract][Full Text] [Related]
4. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
Xu MY; Wong AHC
Acta Pharmacol Sin; 2018 May; 39(5):733-753. PubMed ID: 29565038
[TBL] [Abstract][Full Text] [Related]
5. Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease.
Ambrad Giovannetti E; Fuhrmann M
Brain Res; 2019 Mar; 1707():216-226. PubMed ID: 30503351
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer's Disease Model Mice.
Lu MH; Zhao XY; Xu DE; Chen JB; Ji WL; Huang ZP; Pan TT; Xue LL; Wang F; Li QF; Zhang Y; Wang TH; Yanagawa Y; Liu CF; Xu RX; Xia YY; Li S; Ma QH
J Alzheimers Dis; 2020; 75(1):245-260. PubMed ID: 32280096
[TBL] [Abstract][Full Text] [Related]
7. Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.
Govindpani K; Calvo-Flores Guzmán B; Vinnakota C; Waldvogel HJ; Faull RL; Kwakowsky A
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825683
[TBL] [Abstract][Full Text] [Related]
8. GABAergic Microcircuits in Alzheimer's Disease Models.
Villette V; Dutar P
Curr Alzheimer Res; 2017; 14(1):30-39. PubMed ID: 27539596
[TBL] [Abstract][Full Text] [Related]
9. The basolateral amygdala γ-aminobutyric acidergic system in health and disease.
Prager EM; Bergstrom HC; Wynn GH; Braga MF
J Neurosci Res; 2016 Jun; 94(6):548-67. PubMed ID: 26586374
[TBL] [Abstract][Full Text] [Related]
10. Pinpointing the locus of GABAergic vulnerability in Alzheimer's disease.
Melgosa-Ecenarro L; Doostdar N; Radulescu CI; Jackson JS; Barnes SJ
Semin Cell Dev Biol; 2023 Apr; 139():35-54. PubMed ID: 35963663
[TBL] [Abstract][Full Text] [Related]
11. Similarities and interactions between GABAergic and glutaminergic systems.
Car H; Wiśniewski K
Rocz Akad Med Bialymst; 1998; 43():5-26. PubMed ID: 9972040
[TBL] [Abstract][Full Text] [Related]
12. GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system.
Fritschy JM; Panzanelli P
Eur J Neurosci; 2014 Jun; 39(11):1845-65. PubMed ID: 24628861
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
Newhouse PA; Kelton M
Pharm Acta Helv; 2000 Mar; 74(2-3):91-101. PubMed ID: 10812945
[TBL] [Abstract][Full Text] [Related]
14. Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease.
Rissman RA; Mobley WC
J Neurochem; 2011 May; 117(4):613-22. PubMed ID: 21388375
[TBL] [Abstract][Full Text] [Related]
15. A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD.
Purkayastha P; Malapati A; Yogeeswari P; Sriram D
Curr Med Chem; 2015 May; 22(15):1850 - 59. PubMed ID: 25666800
[TBL] [Abstract][Full Text] [Related]
16. [Neuropsychiatric disorders and GABA].
Fujimori S; Yoneda Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):265-71. PubMed ID: 15658502
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-Beta
Calvo-Flores Guzmán B; Kim S; Chawdhary B; Peppercorn K; Tate WP; Waldvogel HJ; Faull RL; Montgomery J; Kwakowsky A
Molecules; 2020 Feb; 25(3):. PubMed ID: 32041202
[TBL] [Abstract][Full Text] [Related]
18. Role of GABA
Mele M; Leal G; Duarte CB
J Neurochem; 2016 Dec; 139(6):997-1018. PubMed ID: 27424566
[TBL] [Abstract][Full Text] [Related]
19. Increased GABAergic development in iPSC-derived neurons from patients with sporadic Alzheimer's disease.
Tang Y; Han Y; Yu H; Zhang B; Li G
Neurosci Lett; 2020 Sep; 735():135208. PubMed ID: 32615251
[TBL] [Abstract][Full Text] [Related]
20. Change in serotonergic modulation contributes to the synaptic imbalance of neuronal circuit at the prefrontal cortex in the 15q11-13 duplication mouse model of autism.
Saitow F; Takumi T; Suzuki H
Neuropharmacology; 2020 Mar; 165():107931. PubMed ID: 31901366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
